ERS Genomics Limited and DefiniGEN Ltd announced a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents

These high-demand used instruments yield substantial cost savings

The role of a lab planner in designing spaces that encourage new ways of thinking

Partnership combines Intellegens’ proprietary AI technology with Optibrium’s expertise in predictive modeling and compound design

What research laboratories can do before an emergency strikes to better prepare themselves and protect their samples and their data

The government giveth, and the government taketh away

This acquisition contributes to the strategic growth of Metrohm enhancing the company’s capabilities to further develop its Raman product line

Pittcon’s non-profit mission funds grants to colleges, high schools, elementary schools, researchers, and more

On-site field observation, verification, and documentation provide multiple benefits

Comparing test results from various sites will be useless if benchmark samples used to compare laboratory results cannot be duplicated from lab to lab

First phase of a long-term collaboration set to improve the research experience by integrating flagship solutions ChemDraw and Reaxys

The 2019 US budget proposal contemplates a 42.3 percent reduction by 2028 in nondefense discretionary spending, where scientific research dollars are situated